William E. Rote

SENIOR VICE PRESIDENT, R&D

William E. Rote (SENIOR VICE PRESIDENT, R&D) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Travere Therapeutics, Inc. (TVTX). The largest single filing was $13.1M of TVTX (208,778 sh across 5 lots, as filed), executed Sep 15.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 5 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$16.4M

shares × price, as filed

Last traded

Sep 16

Filed Sep 17

Median ADV $123.0M across their filed names

Open performance→

Volume by month

Buys $0 Sells $16.7M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 5 filings

Sector per market data · by filing · past 12 months

Most traded names

TVTX

Travere Therapeutics, Inc. TVTX · 0 buys · 7 sells 7 filings

Recent filings

TVTXSALE Travere Therapeutics, Inc. View filing → $13.1M
208,778 sh across 5 lots
Exec Sep 15
Filed Sep 17 · 9:35 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $121K
2,763 sh × $43.95
Exec May 6
Filed May 6 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $356K
9,100 sh × $39.09
Exec Apr 22
Filed Apr 23 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $409K
12,446 sh × $32.87
Exec Feb 3
Filed Feb 3 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $2.4M
60,000 sh × $40.10
Exec Dec 24 2025
Filed Dec 29 2025 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $122K
5,200 sh × $23.53
Exec Feb 12 2025
Filed Feb 12 2025 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $177K
8,951 sh × $19.78
Exec Feb 3 2025
Filed Feb 4 2025 · 5:30 PM ET